SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-056975
Filing Date
2019-10-28
Accepted
2019-10-28 17:19:45
Documents
14
Period of Report
2019-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921294d1_8k.htm   iXBRL 8-K 22873
2 EXHIBIT 99.1 tm1921294d1_99-1.htm EX-99.1 80458
3 GRAPHIC tm1921294d1_99-1img01.jpg GRAPHIC 7641
  Complete submission text file 0001104659-19-056975.txt   283499

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qure-20191028.xsd EX-101.SCH 3183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20191028_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20191028_pre.xml EX-101.PRE 22708
10 EXTRACTED XBRL INSTANCE DOCUMENT tm1921294d1_8k_htm.xml XML 3353
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 191173876
SIC: 2834 Pharmaceutical Preparations